BioSpace News Archive

Athenex, Inc. announced that collaborators at the Quantum Leap Healthcare Collaborative reported today that the Company’s oral paclitaxel plus encequidar in combination with a PD-1 inhibitor and carboplatin has graduated in the triple-negative subgroup of high-risk early-stage breast cancer.

Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, has received Fast Track designation from the U.S. Food and Drug Administration for its monoclonal antibody candidate, EB05.

Boehringer Ingelheim today announces that the Shareholders have appointed Paola Casarosa and Shashank Deshpande to the Board of Managing Directors.

Invectys, Inc. and CTMC today announced Food and Drug Administration (FDA) clearance of an Investigational New Drug (IND) application for a Phase 1/2a clinical study of IVS-3001, Invectys’s lead engineered human leukocyte antigen A (HLA-G) targeting chimeric antigen receptor (CAR) T cell therapy for the treatment of solid tumors.

Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that the company has nominated ISM4312A as a preclinical candidate targeting DGKA with an AI-identified target and AI-designed structure for immuno-oncology therapeutics.

Stereotaxis announced the successful treatment of patients using the latest Genesis Robotic Magnetic Navigation system by physicians of the nationally recognized Fred & Lena Meijer Heart Center, part of Corewell Health in Grand Rapids, Michigan.

Capio, one of the largest healthcare asset management companies in the country, announced nine internal leadership promotions, including the establishment of three new executive positions.

Centene Corporation (NYSE: CNC) announced today it will present at the JP Morgan 41st Annual Healthcare Conference, to be held Monday, January 9-Thursday, January 12, 2023, at the Westin St. Francis in California.

Cassava Sciences, Inc. (Nasdaq: SAVA) announced today that a valued and long-time member of the Company, Nadav Friedmann, PhD, MD, has died following a brief journey with cancer, only recently discovered.

March of Dimes, the leading organization fighting for the health of moms and babies, is pleased to announce Patricia Hunt, PhD as the recipient of the 2022 Richard B. Johnston, Jr., MD Prize in Developmental Biology.